Eris Lifesciences launches SUNDAE, a generic Semaglutide, in India with affordable multi-dose formats and a forthcoming pen-device, expanding access to GLP-1 therapy.
AI Assistant
ERIS Lifesciences Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.